To proceed to further analysis, PPP was first centrifuged at 2000 g for 20 min and thereafter at 13000 g for 2 min at room temperature. As previously described (24 (link), 25 (link)), the supernatant was incubated with monoclonal antibodies in order to phenotype EVs with antibodies against MPO, conjugated with PE (anti-MPO-PE, Beckman Coulter, Brea, CA, United States), tissue factor (CD142D, NJ, United States), citrullinated histone-3 (anti-H3Cit, Abcam, Cambridge, United Kingdom), and plasminogen (Abcam, Cambridge, United Kingdom). The samples were further fixed (Cellfix, BD, NJ, United States) in order to be evaluated by flow cytometry on a Beckman Gallios instrument (Beckman Coulter, Brea, CA, United States). The EVs gate was determined using Megamix beads (0.3–1.0 μm, BioCytex, Marseille). EVs were defined as particles <1 μm in diameter, according to MISEV guidelines defnition of a medium/large EVs (28 (link)). The measured levels of EVs are presented as EVs/μL plasma. The intra- and inter-assay coefficients of variation for MPO+EVs measurement were <9%, respectively.
Free full text: Click here